Skip to main content

Table 1 Treatments for micro-wounding experiments

From: Interleukin-1, tumor necrosis factor-alpha, and transforming growth factor-beta 1 and integrative meniscal repair: influences on meniscal cell proliferation and migration

Treatments Concentrations Vendor
Serum 0, 1%, 5%, 10% Hyclone (Logan, UT, USA)
Recombinant porcine IL-1α 0, 0.1 ng/mL, 1 ng/mL, 10 ng/mL R & D Systems (Minneapolis, MN, USA)
Recombinant porcine TNF-α 0, 0.1 ng/mL, 1 ng/mL, 10 ng/mL R & D Systems (Minneapolis, MN, USA)
Porcine TGF-β1 0, 0.1 ng/mL, 1 ng/mL, 10 ng/mL R & D Systems(Minneapolis, MN, USA)
10% Serum and factors 10% Serum Hyclone (Logan, UT, USA)
  10% Serum + 10 ng/mL IL-1 see above
  10% Serum + 10 ng/mL TNF-α see above
  10% Serum + 10 ng/mL TGF-β1 see above
  1. Hyclone (Logan, UT, USA); R & D Systems (Minneapolis, MN, USA)